⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Veris Residential, Inc. (NYSE – VRE), XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX)
globenewswire.com
VRE
XOMA
OGN
RMAX
Pure Energie choisit Kraken pour gérer ses actifs éoliens, solaires et de stockage
businesswire.com
OGN
Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders
globenewswire.com
HLX
OGN
XOMA
RMAX
Halper Sadeh LLC is Investigating Whether SLNO, OGN, RMAX, XOMA are Obtaining Fair Deals for their Shareholders
globenewswire.com
SLNO
OGN
RMAX
XOMA
Halper Sadeh LLC is Investigating Whether MKC, LEG, OGN, KW are Obtaining Fair Deals for their Shareholders
globenewswire.com
MKC
LEG
OGN
KW
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
globenewswire.com
XOMA
OGN
RMAX
SLNO
Halper Sadeh LLC is Investigating Whether AVNS, OGN, ESQ, VRE are Obtaining Fair Deals for their Shareholders
globenewswire.com
AVNS
OGN
ESQ
VRE
Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders?
prnewswire.com
OGN
TBRG
CYCN
La Comisión Europea (CE) aprueba POHERDY ® (pertuzumab) de Henlius y Organon, el primer biosimilar de PERJETA (pertuzumab) autorizado en Europa
businesswire.com
OGN
La Comisión Europea (CE) aprueba POHERDY® (pertuzumab) de Henlius y Organon, el primer biosimilar de PERJETA (pertuzumab) autorizado en Europa
businesswire.com
OGN